米力农联合硝酸异山梨酯治疗充血性心力衰竭对患者心功能的影响及安全性

Influence and safety of milinong and nitrate yamanashi ester on cardiac function of patients with congestive heart failure

  • 摘要: 目的:探讨米力农与硝酸异山梨酯联合治疗充血性心力衰竭(CHF)对患者心功能的影响及安全性。方法分析本院自2012年1月-2014年1月收治的112例充血性心力衰竭患者,按照随机数字表法分为治疗组58组和对照组54例,两组均给予常规药物治疗,对照组在此基础上加用硝酸异山梨酯片,治疗组在对照组基础上加用米力农。观察两组临床总有效率、BNP 及超声心电图指标变化及安全性。结果①对照组与治疗组临床总有效率分别为75.9%(41/54),93.1%(54/58),两组比较(χ2=6.428,P <0.05);②两组治疗后与治疗前比较,BNP 水平、CI、CO、LVEF 各项指标比较(P <0.05),治疗后两组比较,BNP 水平、CI、CO、LVEF 各项指标均有显著改善(P <0.05);③治疗组与对照组不良反应发生率为6.9%(4/58)与5.6%(3/54),两组比较(χ2=0.086,P >0.05)。结论米力农与硝酸异山梨酯联合治疗充血性心力衰竭,可以提高临床有效率,改善 BNP 及心电解质水平,且安全性好,值得临床推广应用。

     

    Abstract: Objective To explore the influence and safety of milinong and nitrate yamanashi ester on cardiac function of patients with congestive heart failure (CHF).Methods 112 patients with CHF were randomly divided intotreatment group (n =58)and control group (n =54).All pa-tients were given routine drug treatment,the control group was treated with additional nitrate ya-manashi ester,while the treatment group was treated with additional nitrate yamanashi ester and milinong.Clinical total effective rate,the BNP and ultrasonic cardiogram index change and security werecomparedbetween twogroups .Results The total effective ratewas7 5 .9 % (4 1 /5 4 )and 93.1% (54 /58)in control group and treatment group respectively (χ2=6.428,P <0.05).The levels ofBNP ,CI ,CO ,LVEF after treatment in treatment in groups improved significantly (P <0.05),and the levels of BNP,CI,CO,LVEF after treatment in treatment group were significant-ly better than control group (P <0.05).The incidence rate of adverse reactions was 6.9% (4 /58) and 5.6% (3 /54)in treatment group and control group respectively (χ2 =0.086,P >0.086). Conclusion Application of milinong combined with nitrate yamanashi ester in treatment of CHF can improve the clinical effective rate,the BNP and heart electrolyte level.

     

/

返回文章
返回